Octopamine increases the sensitivity of the Limulus lateral eye in situ when injected beneath the cornea during the day. The effect of octopamine is dose-dependent with a threshold concentration of about 0.1 PM injected at 1 pl/min for 15 min. Injection of 40 PM octopamine increases lateral eye sensitivity to approximately 70% of the nighttime level normally caused by the efferent output of a circadian clock. Injections of octopamine analogues and other candidate neurotransmitters indicate that the postsynaptic receptor mediating the increase of retinal sensitivity is relatively specific for the structure of octopamine. The postsynaptic receptor is tentatively classified as a type 2B octopamine receptor (Evans, P. D. (1981) 
A circadian clock in Limulus brain generates efferent activity in lateral optic nerve fibers at night (Barlow et al., 1977) . The efferent fibers terminate in the retina (Fahrenbach, 1971; and presumably release one or more neurotransmitters (Battelle, 1980) . Efferent neurotransmission in the lateral eye produces marked changes in fundamental processes, such as photoreceptor noise (Kaplan and Barlow, 1980) , sensitivity to light (Barlow et al., 1977; Kaplan and Barlow, 1980) , and the photon-to-spike transduction mechanism (Barlow et al., 1977; . The functional changes may result in part from circadian alterations in retinal morphology and ultrastructure Barlow, 1977,1979; Barlow et al., 1980; Barlow and Chamberlain, 1980 vision. The ventral eyes and the median ocelli, in addition to the lateral eyes, receive input at night from the circadian clock (Eisele et al., 1982; Kass et al., 1983) . Illumination of the median ocellus at night increases efferent activity along the lateral optic nerve, leading to changes in lateral eye sensitivity (R. B. Barlow, Jr., L. A. Westerman, and S. C. Chamberlain, submitted for publication).
Behavioral experiments reveal diurnal changes in visual sensitivity (Powers and Barlow, 1981) and a possible role of vision during mating (Barlow et al., 1982) .
Octopamine may be the neurotransmitter that links the circadian activity from the clock to the changes in structure and function of the lateral eye. It has recently been shown to be synthesized, stored, and released from efferent nerve terminals in the ventral and lateral eyes of Limulus (Battelle et al., 1982) . The purpose of the present study in the lateral eye was to determine (I) a method for subcorneal application of candidate neurotransmitters that mimics the physiological action of endogenous efferent neurotransmitter(s); (2) the threshold and effective concentration range for octopamine; (3) the transmitter specificity for the postsynaptic receptor and the receptor classification; and (4) a pharmacological agent that antagonizes the physiological actions of both exogenous octopamine and endogenous neurotransmit- Barlow, 1980, 1982a) .
Materials and Methods
The methods are essentially the same as described by . Animals freshly caught at Woods Hole generally showed more pronounced circadian rhythms; nevertheless, we found no substantial differences in experimental results obtained between the two locations.
Electrical recording and optical stimulation. During an experiment, animals were fastened to a rigid platform and placed into an aquarium located within a lightproof shielded cage (Barlow et al., 1977) . Electroretinograms (ERGS) were recorded from each lateral eye with a wick electrode placed in contact with the cornea . The electrode was connected to a band-pass differential amplifier (3 to 300 Hz, Electronics Laboratory, Rockefeller University). The reference input to the amplifier was connected to a silver wire inserted beneath the carapace near the eye. Brief flashes of light (10 to 50 msec in duration)
were delivered to the cornea1 surface by either a green light-emitting diode (LED) or a glass fiberoptic bundle transmitting light from a tungsten filament source. When the glass fiberoptic bundle was used, a white Teflon screen was placed in front of the eye to provide uniform illumination of the retina .
Stimulus control, data collection, and analysis. In experiments utilizing the tungsten filament light source, brief pulses of retinal illumination were controlled by electromagnetic shutters (Unbilitz, A. W. Vincent Associates, Rochester, NY) and digital timers (ISR Electronics Shop). The timers also controlled a two-channel strip chart recorder (Gould Brush, Model 220) for a permanent record of the ERGS from both eyes. The peak-to-peak amplitudes of the ERG could be directly measured and plotted as a function of light intensity or of time of day. Experiments using LEDs for retinal stimulation were conducted with the aid of a microcomputer (AIM-65, Rockwell International), together with analogue-to-digital convertors and current drivers (ISR Electronics Shop). In each experiment the microcomputer program was initialized with the cycle time for flash delivery, duration of the LED flashes, and sample rate (typically 2 msec) for the conversion of the ERG responses. The microcomputer determined and printed out the latency of the ERG, its peak-to-peak amplitude, together with the date and the time. In addition, the microcomputer stored peak-to-peak amplitudes of the ERGS for several days (256 ERGS/eye) and, on command, plotted them versus time of day on the strip chart recorder. The program and associated electronic equipment permitted the analysis and storage of ERG data from up to three animals (six lateral eyes) during the course of a single experiment.
Subcorneal injections. Pharmacological agents were dissolved in sea water and delivered to the lateral eye by a hypodermic needle (26 gauge) connected to a syringe pump (Sage Instruments, Model 341). The needle was inserted beneath the cornea by hand or by a hydraulic drive unit (David Kopf Instruments, Tunjunga, CA). In all experiments, solutions were injected at the rate of 1 pl/min. Injection rates greater than 3 pl/min proved deleterious to the retinal responses. The pharmacological agents listed in Table I and tetrodotoxin (TTX) were obtained from Sigma Chemical Company (St. Louis, MI). The "DL" forms of octopamine, synephrine, norepinephrine, and tyrosine were used. Clonidine was obtained from Boehringer Ingelheim (stock); clozapine was from Sandoz (stock). All solutions were freshly prepared with pH adjusted to 7.2 to 7.4.
Results
The ERG of the lateral eye. The ERG was used throughout this study as a measure of the retinal sensitivity of the lateral eye. Hartline (1928) first recorded the ERG from the lateral eye and showed that it had consisted of a simple biomodal wave form. He later showed that its waveform resembled that of the photoreceptor potential (Hartline, 1935) . To investigate further the nature of the lateral eye ERG, we compared the normal ERG response to that recorded in the presence of TTX (Fig. l) , a substance shown to block the sodium channels that give rise to the propagated action potential (Moore et al., 1967) . In this experiment the animal was maintained in complete darkness during the simultaneous recording of Before TTX 4f n After TTX i' \K Figure 1 . ERGS of the lateral eye before and after TTX injection. The animal was maintained in complete darkness during simultaneous ERG recording (shown) and optic nerve recording (not shown). TTX (1 FM) was injected (15 ~1 in 15 min) into the lateral eye until spontaneous and light-driven spike activities were abolished. The peak-to-peak amplitudes of the ERGS are 400 pV, and the records are 0.6 set long. The latency, shape, and duration of the ERG were unchanged by the TTX application. This finding supports our claim that the ERG provides a convenient measure of the primary photoresponse, without complications from spike-initiated processes. 910 Kass and Barlow Vol. 4, No. 4, Apr. 1984 the ERG and extracellular optic nerve activity . The optic nerve recording (not shown) consisted of spike activity from about 50 optic nerve fibers located in a horizontal strip across the eye. The ERG electrode was placed in the middle of the strip. TTX (1 pM) was injected into the eye until spontaneous and light-evoked spike activities were abolished (15 ~1 in 15 min). The latency, shape, and duration of the ERG were unaffected by TTX, indicating that the waveform of the response is not influenced by spike-initiated, secondary retinal processes. In sum, the lateral eye ERG seems to provide a convenient measure of the primary photoresponse.
Circadian and octopamine-induced increases in ERG amplitude. Figure 2 shows the circadian rhythm in the amplitude of the ERG of the lateral eye. The animal was maintained in constant darkness for 3 days, during which time the ERG was evoked by a constant intensity flash every 20 min. As previously shown by Barlow et al. (1977) and , the ERG amplitude increases at around 6 P.M., stays elevated during the nighttime hours, declines in amplitude at about 4 A.M., and remains low during the daytime until the following evening. While cutting the optic nerve abolishes the circadian changes in ERG amplitude, stimulating the distal end of the cut nerve during the day or night mimics the nighttime increase in ERG amplitude; thus, efferent optic nerve activity generated at night from a circadian clock mediates the elevation in ERG amplitude (Barlow et al., 1977; .
Figure 2 also shows that octopamine can mimic, in part, the effects of the circadian clock. During days 2 and 3, octopamine was injected into the eye for 15 min (1 pl/min) at concentrations of 0.05 and 5 pM, respectively. The 0.05 pM injection had no effect, but the 5 pM injection increased the ERG amplitude to about 50% of the natural nighttime level. Figure 3 summarizes the effects of a wide range of octopamine concentrations on ERG amplitude. A total of 49 daytime injections was made, each with one of eight different concentrations of octopamine. Encircled num-0.05 IJM Octopamine + bers denote the number of injections at various concentrations. The vertical position of the encircled number represents the average increase in ERG amplitude corresponding to that concentration, and the vertical bars give the response range. Each change in ERG amplitude is measured relative to the maximum ERG amplitude recorded during the preceding night.
Concentrations of octopamine less than 0.1 pM did not increase the ERG amplitude. In the range of 0.25 to 40 pM, the increase in ERG amplitude is roughly proportional to the concentration. Extrapolation of the data yields a threshold concentration of 0.1 PM octopamine.
Because all concentrations refer to the solutions within syringes, the question arises as to the actual concentration near the efferent nerve terminals within the retina. The volume of a lateral eye into which we injected octopamine was typically 150 ~1. If one assumes no blood flow and no barriers to diffusion, then an injection of 15 ~1 in 15 min would result in a dilution of 1 to 10. To measure blood flow, we removed the cornea of the lateral eye and then measured 3 ml of blood flowing from the eye in a 15-min period, indicating that the volume of blood in the eye may change every 45 sec. This volume change would lead to an additional dilution of about 1 to 20. It would follow, then, that the concentrations of octopamine graphed in Figure 3 probably represent an overestimate of at least two orders of magnitude. The concentration of exogenous octopamine in the retinal tissue at threshold would then be about 1 nM. This concentration of octopamine in the lateral eye would correspond well to thresholds for octopamine effects at receptors in locust (Evans, 1981) .
Intensity-response function of the ERG. Figure 4 plots ERG amplitude as a function of light intensity. Flashes of light were presented during the night and the day and also during the day after octopamine injection. All measurements were carried out under dark-adapted conditions. The "night" data were obtained at 11 P.M., and the "day" data were measured the following morning at 10 A.M. In both experiments, the intensity-response flashes of light at constant intensity that evoked ERGS. Circadian activity at night increases the amplitude of the ERG beginning at around 6 P.M. and continuing until about 4 A.M. Octopamine was injected (15 min; 1 pl/min) into the lateral eyes in the afternoons. Injection of 5 FM octopamine can increase the ERG amplitude during the day to about 50% of its natural nighttime elevation. The rate of the increase in ERG amplitude following octopamine injection is similar to that which occurs naturally in the evening. Figure 2 . On the abscissa are plotted the concentrations of octopamine contained in the syringes. Each encircled number represents the number of lateral eyes injected at that particular concentration. The vertical position of the encircled number represents the average increase in ERG amplitude as. a percentage of the natural nighttime level. Increases of 1% were within the noise level of the ERG recordings and could not be discerned. The uertical bars denote the full response range for the increase in ERG amplitude except at the 1 and 5 pM octopamine injections. At both of these concentrations, the numbers of independent injections were sufficiently large (>lO) to justify a calculation based on 1 SD. Injections of octopamine greater than 0.1 PM were required to obtain an increase in ERG amplitude. The increase in ERG amplitude is roughly proportional to the concentration of injected octopamine between 0.1 and 100 pM. function was measured between 12:30 and 1 P.M. after octopamine had been injected at noon. The experiments with the right lateral eye (Fig. 4B) were carried out 3 days after those with the left eye (Fig. 4A) . In both experiments, shifts of the intensity-response function from day to night exemplify circadian changes in retinal sensitivity . Injection of octopamine mimics, in part, the effects of the circadian clock at night.
Changes in lateral eye sensitivity. The changes in retinal sensitivity can be estimated from the intensity-response functions in Figure 4 . In Figure 4A , the daytime data were fitted by eye with a smooth curve. The same curve, shifted 1.05 log units to the left and 0.4 log unit vertically, overlays the nighttime data. The pronounced lateral shift is consistent with the idea that a major portion of the increase in ERG amplitude at night results frqm structural changes that increase quantum catch (Barlow et al., 1980) . In this case, the lateral shift would correspond to an 11-fold increase in quantum catch. Octopamine (10 pM) injected during the day shifts the curve 0.25 log unit laterally, which corresponds to an approximate doubling of quantum catch. Likewise, in Figure 4B , the curve overlying the nighttime data is shifted 1.73 log units laterally relative to the daytime curve; this corresponds to a 54-fold increase in quantum catch. A higher concentration of octopamine (40 pM) injected into the opposite eye of the same animal leads to a lateral shift in the curve by 1.13 log units, approximating a 14-fold increase in sensitivity. The 10 and 40 pM octopamine injections during the day increased the ERG amplitude to 25 and 65% of the nighttime level. These values correspond well to the dose-response data of Figure 3 .
Taken together, the results in Figures 2, 3 , and 4 indicate that octopamine injected during the day partially replicates the effect of the circadian clock on ERG amplitudes at night. The effect of octopamine is dosedependent. We note that the curve used to fit all sets of data in Figure 4 , A and B is the same as that used by to fit ERG intensity-response data from other horseshoe crabs.
Relative potencies of other pharmacological agents. Table I lists the relative potencies of agonists and analogues of octopamine as well as other neurotransmitters for elevating the amplitude of the ERG of the lateral eye. Potencies of the various agents were arrived at by first . Intensity-response functions for the lateral eye ERG at night and during octopamine injections. Plotted on a log scale is the ERG amplitude (ordinate) as a function of log light intensity(abscissa). Each response was evoked by a 50-msec light flash under dark-adapted conditions. All sets of data in both eyes were fit by the same curve, although intensity-response functions obtained both after octopamine injection and during the night required the curve to be shifted along the ordinate and abscissa relative to the daytime curve. A, During the night and after 10 pM octopamine injection, the intensity-response curve was shifted 1.05 and 0.25 q g log units, respectively, along the abscissa; and 0.2 and 0.1 log unit, respectively, along the ordinate. The increased sensitivity occurring during the night and after the .JJ 10 pM octopamine injection can be explained in terms of an ll-and a 2-fold increase in the number of photons caught by the photoreceptors. B, In the opposite 2 lateral eye, the intensity-response curves obtained during the night and 40 pM octopamine injection were shifted 1.73 and 1.13 log units along the abscissa and 0.2 9 and 0.1 log unit along the ordinate. The increased sensitivity during the night and after the 40 pM octopamine injection can be explained in terms of a 54-and a 14-wti fold increase in the number of photons caught by the photoreceptors. determining the concentration required to increase the ERG amplitude by 10 to 60% of the nighttime level. Assuming that the middle range for the dose-response data for octopamine in Figure 3 is representative of the action of all agents, we then determine the concentration that would have yielded an amplitude increase of 35%, which is equal to that produced by 10 pM octopamine. We define the relative potency to be the ratio of this concentration of the agent to 10 pM octopamine. Note that in Table I only naphazoline, tolazoline, synephrine, and clonidine, which are all known agonists of octopamine (Evans, 1981) , were relatively effective in increasing ERG amplitude.
These agonists do not occur in nature. Norepinephrine, dopamine, y-aminobutyric acid (GABA), 5-hydroxytryptamine (5HT; serotonin), and acetylcholine (ACh) were relatively ineffective. Although these biogenic amines are neurotransmitters in many neural tissues, none has yet been found in Limulus lateral eye (Battelle, 1980) . GABA can be synthesized by Limulus retina from exogenously applied precursor, but the amounts of GABA synthesized are three orders of magnitude smaller than amounts synthesized for octopamine (Battelle, 1980) . Also, GABA was two orders of magnitude less potent than octopamine. Tyrosine, which is a precursor and analogue of octopamine, had no measurable effect on the amplitude of the ERG.
Antagonism of octopamine-induced and nighttime increases in ERG amplitude. If octopamine is the efferent neurotransmitter that mediates the action of the circadian clock on the retina, then an octopamine antagonist should suppress the clock's action. Clozopine is a potent a-adrenergic antagonist (Berthelsen and Pettinger, 1977) and a general octopamine antagonist in other invertebrate systems (Harmer and Horn, 1977; Dougan and Wade, 1978; Evans, 1981) . In the experiment shown in Figure 5 , we injected octopamine (1 PM) plus clozapine (25 pM) during the day (bar) in the left eye (LE). Into the right eye (RE) we injected only octopamine (1 PM). Subsequently, the ERG amplitude of the right eye increased, while that of the left eye did not. Neither of the injections that were made at midday impaired the natural action of the clock on ERG amplitude which began at about 6 P.M. We would expect clozapine's action to require continuous injection because of the rapid blood flow into and out of the retina. Figure 6 shows that clozapine can antagonize the endogenous nighttime elevation in the amplitude of the ERG. In this experiment, clozapine (25 FM) was injected at night (bar) in the left eye and normal saline into the right. Clozapine decreased the amplitude of the ERG toward the daytime level. After injection stopped, the amplitude of the ERG returned to the normal nighttime level. Thus, clozapine antagonizes the endogenous nighttime and the exogenous octopamine-induced elevation in the ERG amplitude. Therefore, we conclude that octopamine may be an efferent neurotransmitter of the circadian clock's action on the retina. Pharmacological controls. In most experiments, a pharmacological agent was injected into one eye while normal saline (with or without 1% dimethyl sulfoxide or ethanol) was simultaneously injected into the other (e.g., Fig. 6 ). The ERG response from the eye into which saline was injected served as a control against general druginduced metabolic effects. This was important given that Evans et al. (1976a, b) and Kravitz et al. (1976) have shown that octopamine acts as a general neurohormone in lobster, and that Augustine et al. (1982) and Lumis et al. (1982) indicate in preliminary results that octopamine may also have widespread effects in Limulus. We have found that an agent injected into one eye never produced an effect in the opposite eye (n = 30). Thus, in some experiments it was possible to compare the relative potencies of two different agents by using both lateral eyes of the same animal. Whenever practical, the syringe needles carrying the drugs were reversed on subsequent days in order to determine the drug's action in the opposite eye. In addition, we could inject a drug and its antagonist into one eye and directly compare their action to the drug alone in the opposite eye (e.g., Fig. 5 ). In sum, we used the opposite lateral eye either to control against nonlocalized drug effects or to compare the actions of different drugs.
Discussion
Octopamine as an efferent neurotransmitter.
Octopamine has fulfilled five criteria toward its identification as a neurotransmitter in Limulus lateral eye; namely, octopamine has been shown (1) to be synthesized from its precursors, (2) to be localized intracellularly, (3) to be released from efferent nerve terminals, (4) to mimic the physiological actions of the endogenous neurotransmitter, and (5) to be blocked pharmacologically.
Battelle (1980) originally showed that octopamine was endogenously present in the Limulus lateral eye; in addition, she showed that octopamine could be synthesized Vol. 4, No. 4, Apr. 1984 . Clozapine's antagonism of the endogenous nighttime increase in ERG amplitude. The lateral eyes were dark-adapted, and the ERGS were sampled every 15 min for the 2-day period shown. During the second night, 25 pM clozapine was injected for 90 min (b&h bar) into the left eye (solid circles); during the same time, saline was injected into the right eye (open circles). The amplitude of the ERG from the eye with clozapine decreased toward the daytime level, whereas the ERG from the saline-injected eye exhibited no change. After we stopped the injection of clozapine, the ERG amplitude increased to the nighttime level. Thus, while injected, clozapine antagonized the natural nighttime elevation in ERG amplitude.
The Journal of Neuroscience Neurotransmission of Circadian Rhythms 915 from radioactively labeled precursors. She hypothesized that octopamine may be the efferent neurotransmitter. Battelle et al. (1982) combined biochemistry, autoradiography, and electron microscopy to demonstrate that octopamine, synthesized in the lateral eye from radioactive precursors, was present in only the efferent nerve terminals. This labeled octopamine was shown to be released into the extracellular fluid under conditions of high external potassium concentrations that were Ca2+ dependent. These studies established criteria 1, 2, and 3 listed above.
Our studies established criteria 4 and 5. We showed that octopamine reproduces the effect of the circadian clock on the ERG response. We also showed that clozapine, a general octopamine antagonist, antagonizes both the physiological action of exogenous octopamine and of endogenous neurotransmission.
Thus, all evidence points to octopamine being an efferent neurotransmitter in Limulus.
At present, however, we cannot be certain whether octopamine is the only transmitter involved in efferent neurotransmission.
High concentrations of octopamine (25 to 40 yM), when injected into the lateral eye during the day, dramatically increased the ERG amplitude, although rarely to the natural nighttime level. In contrast, activating the efferents via optic nerve shock increases the ERG amplitude several times the natural nighttime elevation . It may be that our method of injection does not adequately mimic the natural release of neurotransmitter.
Another possibility is that the endogenous activity may involve an additional neurotransmitter that modulates octopamine's postsynaptic action. There is some evidence that neuropeptides are present in the Limulus brain and the lateral eye (Chamberlain and Engbretson, 1982) . Therefore, it is possible that neuropeptides participate in mediating the circadian clock's action on the retina. This possibility is presently under investigation.
The cellular mechanisms that mediate the efferent effects in the retina are not yet understood.
The ultrastructural appearance of the efferent nerve terminals indicates that transmission may involve a neurosecretory process (Barlow and Chamberlain, 1980; Fahrenbach, 1981; Battelle et al., 1982) . Perhaps octopamine or a second transmitter released with octopamine functions as a local neurohormone.
Octopamine in other nervous systems. Octopamine has been detected in the vertebrate brain, but its role is controversial (see Robertson and Juoria, 1976; Evans, 1981) . In several invertebrates, octopamine appears to function as a neurohormone or neurotransmitter. In lobster, octopamine has been shown to be released from identified neurons, its neurohormonal action being somewhat analogous to that of norepinephrine in vertebrates (Evans et al., 1976a, b; Kravitz et al., 1976) . Octopamine receptors have been characterized in isolated ventricles in the mollusc Tapes watlingi, but the mode of action is not clear (Dougan and Wade, 1977, 1978) . In locust, octopamine appears to function as a neurohormone in mediating muscular activity (Candy, 1978; Goosey and Candy, 1980) . Its action has been studied in detail in locust O'Shea, 1977,1978; O'Shea and Evans, 1979; Buchan and Evans, 1980; Evans, 1981) , and a recent result shows that octopamine reduces the degree of catch tension in muscle (Evans and Siegler, 1982) . It is interesting to note that octopaminergic neurons seem to enhance the degree of catch tension in muscles of the insect Hermideina femorata (Hoyle, 1982) . In the firefly light organ, octopamine appears to act as a classical neurotransmitter (Carlson, 1968; Robertson and Carlson, 1976; Nathanson, 1979) . To date, Evans (1981) provides the most comprehensive study on the different classifications of octopamine receptors. He studied the effects of various agonists and antagonists of octopamine on three different components of neuromuscular activity on the locust extensor-tibia muscle preparation.
He concluded that three pharmacologically distinct octopamine receptors mediate each one of the three neuromuscular activities. The octopamine type 1 receptor mediates the slowing of a myogenic rhythm found in a specialized proximal bundle of muscle fibers. The type 2A receptor mediates the increase in amplitude of slow motor neuron twitch tension. The type 2B receptor mediates the increase in relaxation rate of twitch tension induced by firing either the fast or the slow motor neuron. Evans pointed out that octopamine receptors in the locust extensor-tibia neuromuscular preparation have many similarities with octopamine receptors from other insects (Harmer and Horn, 1977; Nathanson, 1979) , from crustaceans (Battelle and Krav itz, 1978) , and from molluscs (Dougan and Wade, 1978; Batta et al., 1979) . One similarity is that synephrine has been consistently shown to be more potent than octopamine at the octopamine receptor when both substances are exogenously applied to in vivo preparations. Evans suggested that the most likely explanation for synephrine's greater potency involves either drug-dependent access to the octopamine receptor site or inactivation at different rates by enzymes and specific uptake systems.
Comparison between our results and those of Evans (1981) suggests that octopamine-induced increases in ERG amplitude in Limulus lateral eye may be mediated by type 2B octopaminergic receptors. For type 1 receptors, clonidine would be expected to be about 20 times more potent than naphazoline, but we find just the opposite to be the case. According to Evans's description for type 2A receptors, naphazoline would be expected to be about 50 times more potent than tolazoline; however, we find these drugs nearly equal in potency. As listed in Table I , we have found naphazoline and tolazoline to be equally potent. We have noted that both of these octopamine agonists are much more potent and more effective than clonidine. Taken together, these relative potencies closely agree with those expected for type 2B octopamine receptors in locust described by Evans. The close agreement between the ordering of relative potencies of octopamine, naphazoline, tolazoline, and clonidine in our studies and those of Evans (1981) suggests that the increase in ERG amplitude in the lateral eye may be mediated by a single class (type 2B) of octopaminergic receptor.
A comparison between our results and those of other 916 Kass and Barlow Vol. 4, No. 4, Apr. 1984 investigators who have worked on octopamine receptors Candy, D. J. (1978) Barlow, 1977; Barlow et al., 1980) . In preliminary reports zapine and metoclopranide. Clin. Exp. Pharmacol. Physiol. 5: 341-349. (Kass and Barlow, 1981; 1982b) , we showed that exoge-Eisele, L. E., L. Kass, and R. B. Barlow, Jr. (1982) Circadian nous octopamine during the day can also mimic these clock generates efferent optic nerve activity in the excised nighttime changes in retinal structure and function. We Limulus brain. Biol. Bull. 163: 382. will fully report these additional findings in a subsequent Evans, P. D. (1981) 
